VGS wanted to raise awareness of its VEST technology with cardiac surgeons and cardiologists in key European markets.
While there was a wealth of patient data available about VEST, a key challenge was that VGS was largely unknown to key European media. To address this, the campaign was two-pronged, focused on introducing VGS as an innovative company to the media, and also raising awareness of VEST using data from clinical trials and highlighting its potential to revolutionise CABG.
Pascale made introductions to key media in the UK and Germany, with briefings at key cardiac surgery meetings including DGTHG in Leipzig. This combined with the the interim results of the VEST III study, resulted in coverage in top tier publications including Cardiovascular News, Herzmedezin and Perfusion.